Presentations


Xbrane Company Presentation November 2021

Xbrane Company Presentation

Press Releases

29 Oct 2021

Xbrane Biopharma releases interim report for January – September 2021

28 Oct 2021

Invitation to presentation of Xbrane Biopharma’s interim report January – September, 2021 on October 29, 2021.

27 Oct 2021

Xbrane announces four more patents granted

18 Oct 2021

Xbrane Biopharma presents Nomination Committee

11 Oct 2021

Xbrane announces two granted patents that strengthens its high yield protein expression platform

07 Oct 2021

Xbrane Biopharma and AGC Biologics enter into an Agreement to Manufacture Xcimzane™ for Clinical Development

30 Sep 2021

Xbrane Biopharma AB announces that partner STADA’s Marketing Authorization Application for ranibizumab is submitted and validated by European Medicines Agency

13 Aug 2021

Xbrane Biopharma releases interim report for January – June 2021

11 Aug 2021

Invitation to presentation of Xbrane Biopharma’s interim report January – June, 2021 on August 13, 2021.

Financial Reports

18 Apr 2013

Annual report 2013 (available in Swedish only)

18 Apr 2014

Annual report 2014 (available in Swedish only)

31 Dec 2015

Annual report 2015 (available in Swedish only)

18 Dec 2015

Year-end report 2015 (available in Swedish only)

18 Apr 2015

Interim report January – September 2015 (available in Swedish only)

Financial Calendar

16 Feb 2022

Year-end report 2021

31 Mar 2022

Annual report 2021

28 Apr 2022

Interim report January – March 2022

05 May 2022

Annual General Meeting

22 Jul 2022

Interim report January – June 2022

Contact Investor Relations

Anette Lindqvist, CFO & Head of Investor Relation

Presentations and media


PRESENTATION AT PARETO HELTHCARE CONFERENCE

September 3, 2020

Presentation at LSX Nordic Congress

August 29, 2019

Presentation at BioStock Live

March 20, 2019